Does hyperbaric oxygen therapy (HBOT) affect telomere length and senescent cell concentrations in healthy aging adults?
Hyperbaric oxygen therapy (Aging (Albany NY) 2020, PMID 33206062) — b cell telomere length showed the most significant increase, rising by 25.68% at session 30, 29.39% at session 60, and 37.63% post-HBOT. The study involved a specific HBOT protocol and a relatively small sample size of healthy, independently living adults, which may limit generalizability.
Source: Aging (Albany NY) 2020, PMID 33206062 ↗ · Research map · How Magellan grades evidence · evidence confidence: high
Aging (Albany NY) · 2020 · PMID 33206062 · DOI 10.18632/aging.202188
Hyperbaric oxygen therapy significantly increased telomere length and reduced senescent cell percentages in various immune cells in healthy older adults.
The question
Does hyperbaric oxygen therapy (HBOT) affect telomere length and senescent cell concentrations in healthy aging adults?
What they tested
Repeated intermittent hyperoxic exposures, such as certain HBOT protocols, may induce regenerative effects that could impact telomere length and cellular senescence.
How they did it
Thirty-five healthy adults, aged 64 and older, received 60 daily HBOT exposures. Whole blood samples were collected at baseline, after 30 and 60 sessions, and 1-2 weeks post-HBOT. Peripheral blood mononuclear cells (PBMCs) were analyzed for telomere length and senescence.
What they found
Telomere length in T helper, T cytotoxic, natural killer, and B cells increased significantly by over 20% after HBOT. B cell telomere length showed the most significant increase, rising by 25.68% at session 30, 29.39% at session 60, and 37.63% post-HBOT. There was a significant decrease in senescent T helper cells by -37.30% post-HBOT and senescent T-cytotoxic cells by -10.96% post-HBOT.
| 30 Sessions | 25.68 | |
|---|---|---|
| 60 Sessions | 29.39 | |
| Post-HBOT | 37.63 |
Percentage increase in B cell telomere length at different stages of hyperbaric oxygen therapy.
What it means
Hyperbaric oxygen therapy (HBOT) may induce significant senolytic effects in aging populations, including increasing telomere length and clearing senescent cells.
Limitations
The study involved a specific HBOT protocol and a relatively small sample size of healthy, independently living adults, which may limit generalizability.
The paper at a glance
| Title | Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial |
|---|---|
| Journal | Aging (Albany NY) |
| Year | 2020 |
| PMID | 33206062 ↗ |
| DOI | 10.18632/aging.202188 ↗ |
| Topic | Senescence, senolytics & the hallmarks of aging |
Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗
Molecules & mechanisms in this paper
Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.
Cite this page
These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.
Magellan Longevity. (2026). Does hyperbaric oxygen therapy (HBOT) affect telomere length and senescent cell concentrations in healthy aging adults? [Plain-English summary of Aging (Albany NY) 2020, PMID 33206062, DOI 10.18632/aging.202188]. Magellan Longevity. https://magellanlongevity.com/study/hbot_telomere.html@misc{magellan_hbot_telomere,
title = {Does hyperbaric oxygen therapy (HBOT) affect telomere length and senescent cell concentrations in healthy aging adults?},
author = {{Magellan Longevity}},
year = {2026},
howpublished = {\url{https://magellanlongevity.com/study/hbot_telomere.html}},
note = {Plain-English summary of PubMed PMID 33206062; DOI 10.18632/aging.202188; Aging (Albany NY) 2020. Reviewed by Gabriel Radu, DO},
urldate = {2026-08-11}
}https://magellanlongevity.com/study/hbot_telomere.htmlRelated studies in the Magellan library
- Cellular Senescence: A Translational PerspectiveEBioMedicine · 2017 · PMID 28416161
- Senolytic drugs: from discovery to translationJ Intern Med · 2020 · PMID 32686219
- Fisetin is a senotherapeutic that extends health and lifespanEBioMedicine · 2018 · PMID 30279143
- Does taurine deficiency contribute to aging, and can taurine supplementation improve health…Science · 2023 · PMID 37289866
- Insights into the therapeutic strategies for aging and aging-associated diseasesSignal Transduction and Targeted Therapy · 2026 · PMID 42225652
- Leukocyte telomere length, cancer incidence and all-cause mortality among Chinese adultsInt J Cancer · 2020 · PMID 33459354
All 8 Magellan summaries on senescence, senolytics & the hallmarks of aging →
Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →